Farletuzumab

Farletuzumab (MORAb-003) is a monoclonal antibody which is being investigated for the treatment of ovarian cancer.

This drug was developed by Morphotek, Inc.

It is targeted at FR-alpha which is overexpressed in some cancers such as ovarian cancer.